AI-NATIVE MARKET COVERAGEA daily public coverage recordEach day, the AI expert panel selects one or more market theses, then follows them through data, narrative, expert lenses and panel transcripts.

Follow the thesis. Read the evidence. See what happened next.

TrydingDay, also known as Tryding, is an open, append-only record of selective AI-native market coverage focused on listed companies, financial markets and data-driven analysis. Each day, the data pipeline surfaces potential candidates, and the AI expert panel selects one or more market theses for public coverage. Each selected episode begins with a defined thesis, a base price and the evidence available at that moment. We follow it through fresh market observations and narrative updates across 15 market sessions. The transcript in each publication and relevant update preserves how the panel’s distinct analytical lenses challenge, refine or support the thesis, alongside what changed, what held and what remains uncertain.

Subscribe for coverage updates

Under active coverage

Under observation

These are the episodes currently under public follow-up. Their original thesis, base price, latest evidence and current market reading remain together in one place.

The observation window is 15 market sessions before an episode moves to the wider public record.

New publications lead the list. Meaningful unread updates may bring an older publication forward, but never above a newer one. Most relevant prioritises those updates; Chronological follows the original publication date.

BZUNBaozun Inc.Updated atSession 10Base: $2.87Raw Try
Initial thesisThe Desk selects BZUN as Raw Try. Five ordered observations held the move between 2.855 and 2.869; the latest price was 0.31% above VWAP and the twenty-session return was 9.50%, 8.74 percentage points above its sector. The case is not stronger because volume ratio was only 0.44, money flow was neutral, breadth was not captured, and the sealed information did not prove a same-day company mechanism.
Published at 💬
Broader Market Context The day read as a narrow risk-on session: softer oil and benign inflation eased pressure on rates and the dollar, while the tape remained selective and participation was not fully measurable. The main contradiction was relief in macro pricing alongside uneven sector and risk appetite.
Latest updateBZUN's tracked result improved 9.38 points to +7.67%, and today's capture is up 8.51% above VWAP at 3.04. The recovery restores the price test, but distribution and the still-unverified event link leave durable continuation unresolved.
BZUN observed price path
BZUN directional trendlines and relative performance versus sector
Relevant update at 💬
$2.92 +3.55% Today +1.74% base
CLBTCellebrite DI Ltd.Updated atSession 9Base: $11.06Raw Try
Initial thesisCLBT is the day's most researchable candidate, not a confirmed Try of the Day. The useful question is whether the post-reset bid can hold above VWAP with continued participation.
Published at 💬
Broader Market Context The session sits between record-high index conditions and a more nervous cross-asset backdrop. Futures wavered after the highs, oil remained sensitive to Iran and Hormuz risks, Treasuries were slightly weaker, the euro was firmer, and gold was pulled lower by profit-taking despite rate support. The result is a market that can reward selective strength while punishing unsupported narratives.
Latest updateCLBT's tracked result improved 4.61 points to +9.67%, with today's capture up 4.73% and 0.50% above VWAP at 12.11. Accumulation keeps the post-reset repair test alive, but the large Technology lag and missing confirmed structure leave recovery unproven.
CLBT observed price path
CLBT directional trendlines and relative performance versus sector
Relevant update at 💬
$12.17 +4.73% Today +10.04% base
FIVNFive9, Inc.Updated atSession 14Base: $33.51Raw Try
Initial thesisFive9 is the strongest research case in today's comparison. The stock rose 18.12%, held above the captured VWAP at 32.24, showed an upward intraday trend, and outperformed QQQ by 17.24% in the review data. The candidate-specific thesis is AI-led operating improvement after reported Q2 revenue above guidance and 78% AI-revenue growth. Confirmation is incomplete: the move is 3.04 ATR above its EMA reference, RSI is 70.58, the information set includes a full-year guidance concern, and the market-evidence block lacks complete breadth. The next check is whether FIVN holds above 32.24 while participation remains constructive. A decisive loss of that level with failure to recover would falsify the near-term read.
Published at 💬
Broader Market Context A surprisingly weak jobs report pulled down the dollar, softened rate-hike fear and lifted parts of the equity tape, while AI demand and gold flows kept the session selective. The day was constructive, but it was not a single risk-on switch.
Latest updateFIVN repaired its price structure today, but the improvement is still running on a thin tape. The operating-improvement case remains plausible, while fading participation and the unresolved guidance conflict leave renewed demand unconfirmed.
FIVN observed price path
FIVN directional trendlines and relative performance versus sector
Relevant update at 💬
$34.01 +6.28% Today +1.49% base
MRNAModerna, Inc.Updated atSession 4Base: $151.62Raw Try
Initial thesisMRNA becomes the day's Raw Try because its company-linked vaccine evidence creates a specific thesis worth following. The panel does not treat the sharp move as proof of continuation: the stock is extended, late intraday structure weakened, and the next check is renewed demand after the initial repricing.
Published at 💬
Broader Market Context The day's backdrop was a rebound-prone, cross-asset market that granted volatility without proving persistence. MRNA's company-linked vaccine mechanism earned a research case, while late weakness and missing follow-through kept the Raw Try thesis conditional.
Latest updateMRNA's tracked result fell 4.60 points to -3.43% as today's capture dropped 3.35% but held 0.35% above VWAP at 144.15. The vaccine-linked case remains specific and Healthcare-relative strength is exceptional, yet the lower-range move leaves renewed demand unresolved.
MRNA observed price path
MRNA directional trendlines and relative performance versus sector
Relevant update at 💬
$141.10 -5.72% Today -6.94% base
NPWRNET Power Inc.Updated atSession 3Base: $1.99Try
Initial thesisNPWR is the strongest comparative Try of the Day because the review data combines an orderly breakout, above-VWAP trade, meaningful participation and a specific earnings-linked strategic pivot. It is not the least risky name; it is the case with the clearest next test and falsifier after the alternatives were challenged.
Published at 💬
Broader Market Context The wider market is entering a headline-heavy week: sanctions and oil risk sit beside a major Nvidia event and a closely watched Federal Reserve speech. Index breadth has been healthier than the noisy tape suggests, but rates, geopolitics and AI valuation concerns can still change the regime quickly. NPWR's sealed selection therefore remains a local, testable breakout case inside a less forgiving macro backdrop.
Latest updateNPWR's tracked result improved 4.12 points to -4.93%, while today's capture rose 2.76% and held 1.09% above VWAP at 1.84. That reopens the repair test, but the breakout above 2.00 and durable demand remain unresolved.
NPWR observed price path
NPWR directional trendlines and relative performance versus sector
Relevant update at 💬
$1.86 +3.04% Today -6.28% base
SMTCSemtech CorporationUpdated atSession 1Base: $137.74Try
Initial thesisSemtech is the day's Try of the Day after combining a concrete earnings-linked catalyst with exceptional participation and strong technology-sector relative performance. The thesis remains conditional: the next observable test is a reclaim of 139.58 VWAP while holding the named 131.01 extension reference with renewed participation. Failure to do so would weaken the continuation case.
Published at 💬
Broader Market Context The day was defined by selective breadth, elevated inflation, higher yields, falling but geopolitically sensitive oil and a major Nvidia event. The wider backdrop supports careful stock selection but does not validate every single-stock move. No usable current-window X/Twitter details were available, so no X claim was added.
Latest updateSMTC's tracked result improved 2.19 points to +4.41%, but today's capture rose only 1.22% and sits 0.97% below VWAP at 143.91 in the lower part of its range. The earnings-linked case remains notable; below-VWAP trade and absent structure leave durability unresolved.
SMTC observed price path
SMTC directional trendlines and relative performance versus sector
Relevant update at 💬
$142.65 +1.31% Today +3.56% base
CBRSCerebras Systems Inc.Updated atSession 8Base: $252.22Try
Initial thesisCBRS is the Try of the Day because the current evidence connects a specific AI-infrastructure catalyst with a market move that has not immediately failed. The next observable check is whether price holds the breakout area and VWAP with participation. A loss of that area while volume fades would invalidate the continuation reading.
Published at 💬
Broader Market Context The session sits near record highs, but the surface is not uniform: strong earnings and a resilient index coexist with inflation, labor, energy and rate uncertainty. The broad question is whether leadership can widen without turning into a fragile chase.
Latest updateCBRS's tracked result improved 0.22 points to -28.81%, but today's capture slipped 0.14% and remains 0.61% below VWAP at 183.00. The failed breakout is still unrepaired, and the Technology lag keeps the AI-infrastructure continuation thesis materially weakened.
CBRS observed price path
CBRS directional trendlines and relative performance versus sector
Relevant update at 💬
$182.88 +0.40% Today -27.49% base
KURAKura Oncology, Inc.Updated atSession 2Base: $13.79Try
Initial thesisThe panel selected Kura Oncology as the Try of the Day after comparing the corrected 27-name field. Its insider purchase, reported treatment demand and above-VWAP structure provide the clearest prospective case, while the stretched move and wide quoted spread keep the thesis conditional.
Published at 💬
Broader Market Context The session was broad but uneven: falling oil and lower yields eased macro pressure, while sanctions and Hormuz risk stayed live. Breadth was mildly positive, but leadership rotated toward healthcare, energy and materials as technology and industrials cooled. The room's conclusion is a selective, event-sensitive tape, not a clean risk-on trend.
Latest updateKURA's tracked result improved 0.65 points to -4.92%, and today's capture rose 0.23% while holding 0.23% above VWAP at 13.06. The treatment-demand and insider-purchase case remains specific, but neutral flow and no confirmed structure leave follow-through unresolved.
KURA observed price path
KURA directional trendlines and relative performance versus sector
Relevant update at 💬
$13.25 +1.42% Today -3.95% base
TVTXTravere Therapeutics, Inc.Updated atSession 15Base: $64.44Early Try
Initial thesisTVTX is the committee's Early Try after a 12.03% setup move on 2.95x volume, 12.23% excess performance and a complete trajectory. The current quote is still positive, but the thesis remains conditional because current volume is 0.65x and the available information is unverified. This is watch-only research, not a trade instruction.
Published at 💬
Broader Market Context Markets waited on Middle East talks and employment data as tech leadership weakened, oil stabilized and gold held near a seven-week high. The day was defined by hesitation rather than a missing story.
Latest updateTVTX's tracked result improved 0.02 points to +4.16% as the latest capture gained 0.16% and held 0.74% above VWAP near the top of its range. Healthcare-relative strength and rising averages support repair, but participation is only 0.65 times average with decelerating flow and no confirmed structure, so the early thesis is holding rather than proving continuation.
TVTX observed price path
TVTX directional trendlines and relative performance versus sector
Relevant update at 💬
$67.21 +0.13% Today +4.30% base
TEMTempus AI, Inc.Updated atSession 5Base: $67.88Try
Initial thesisTEM is the panel's Try of the Day. The catalyst is supported by strong participation and structure, while extension keeps the thesis conditional.
Published at 💬
Latest updateTEM's tracked result improved 1.33 points to +2.57%, and today's capture rose 1.30% while holding 0.70% above VWAP at 68.89. Strong Healthcare-relative performance keeps the event-driven case specific, but decelerating participation leaves this as repair rather than confirmation.
TEM observed price path
TEM directional trendlines and relative performance versus sector
Relevant update at 💬
$71.26 +4.06% Today +4.98% base
SMCISuper Micro Computer, Inc.Updated atSession 11Base: $35.78Raw Try
Initial thesisThe comparison favored SMCI over stronger-looking but less balanced alternatives. Its sealed trajectory improved from 13.12% to 17.99% as volume rose, and the stock remained above the supplied VWAP near the top of its range. The move is extended, however, and the evidence still leaves open whether the reaction can hold after the initial event premium fades. NBIS carried greater raw momentum, while CAVA, HRB, DFTX and CRWV each offered credible but more compromised combinations of structure, provenance or risk.
Published at 💬
Broader Market Context The supplied day-first context described a split session: muted Dow and S&P futures ahead of CPI, firmer Nasdaq tone, elevated oil and geopolitical risk, and unusually low S&P 500 dividend yield. The fresh public-web reopening was unavailable, so the contextual read remains partial rather than a complete live-news confirmation.
Latest updateSMCI's tracked result improved 2.67 points to +2.95%, while today's capture rose 2.11% but remained below VWAP at 38.57 with no confirmed structure. Technology-relative strength keeps the context supportive; the tape still tests whether the event premium can hold.
SMCI observed price path
SMCI directional trendlines and relative performance versus sector
Relevant update at 💬
$38.50 +2.97% Today +7.60% base
LFSTLifeStance Health Group, Inc.Updated atSession 13Base: $12.40Raw Try
Initial thesisLFST is a Raw Try because its sealed packet pairs a candidate-specific Q2 margin-and-specialty-services narrative with a 14.39% move, 1.57x volume, 14.51% excess performance versus QQQ, and a coiled, trend-stacked state. Confirmation is incomplete: the intraday signal is below VWAP (12.04) with a down trend, and extension is 3.08 ATR.
Published at 💬
Broader Market Context U.S. stocks held near records while oil rose as the reopening of the Strait of Hormuz remained conditional and the 10-year Treasury yield moved higher. Recent labor data reduced some near-term rate-hike pressure, but energy kept inflation risk alive and AI capex supported leadership selectively. The session rewarded attention, not broad continuation.
Latest updateLFST's tracked result improved 0.20 points to -1.06%, but today's small gain remains 0.13% below VWAP at 12.20 with no confirmed structure. Healthcare-relative strength keeps the margin-and-services case alive; low participation and fading flow leave repair unconfirmed.
LFST observed price path
LFST directional trendlines and relative performance versus sector
Relevant update at 💬
$12.32 +1.40% Today -0.65% base
INFYInfosys LimitedUpdated atSession 7Base: $11.89Raw Try
Initial thesisThe panel selected INFY as a researchable daily thesis after comparing the full sealed candidate set. Its company-specific mechanism and current relative strength are useful, but quiet participation and an incomplete higher-timeframe recovery keep the conclusion conditional.
Published at 💬
Broader Market Context The session was split rather than uniformly weak: oil and geopolitical tension pressed on risk appetite, while optimistic index commentary competed with a softer tape. Breadth was negative overall, especially in smaller names, and the available market cut was partial. The result was a day where headlines could attract attention but participation and follow-through remained selective.
Latest updateINFY's tracked result improved 1.13 points to -0.59%, and today's capture rose 0.98% to sit 0.21% above VWAP at 11.78. That improves the immediate price read, but quiet participation, no confirmed structure and a large Technology lag keep the collaboration case under pressure.
INFY observed price path
INFY directional trendlines and relative performance versus sector
Relevant update at 💬
$11.94 +2.10% Today +0.38% base
CATCHUpdated atSession 6Catch
Initial thesisSixteen candidates were compared against the same market backdrop. Several showed usable secondary execution observations, but no candidate combined a verified mechanism with confirmed structure and near-term continuation. The session therefore produced no public Try of the Day.
Published at 💬
Candidates reviewed: MRK · UUUU · TGT · OPRAToday’s public contextThe session took place against a mixed backdrop: oil remained firm as Hormuz tensions persisted; gold moved higher as the dollar and Treasury yields eased; and futures weakness with AI-linked losses placed the broader rally near a key test. The interaction of geopolitical, cross-asset and index forces raised the proof burden for any candidate-specific daily selection. 2 Software Stocks on Our Watchlist and 1 We Turn Down Dow Jones Futures Fall; After Sandisk, Micron, Credo Lead AI Losses, Market Rally Nears Key Test Gold Edges Higher as Dollar and Treasury Yields Ease Before Fed Minutes
DUKDuke Energy CorporationUpdated atSession 12Base: $122.80Raw Try
Initial thesisDUK combines an ordered constructive path with a concrete candidate-specific event that can be checked and falsified. TMO is the strongest dissenting medium-term comparator, but its five-year catalyst is not a current mechanism and its tape is extended.
Published at 💬
Broader Market Context The day-first context is a mixed and uncertain US market backdrop: index futures are muted/wavering, the US-Iran impasse is lifting oil prices, and the brief flags possible future earnings-growth risk. It informs uncertainty and keeps the daily candidate decision separate from the market narrative.
Latest updateDUK's tracked result fell 0.90 points to -1.64% as today's capture declined 1.14% and slipped 0.07% below VWAP at 120.59. Fading participation, falling averages and a Utilities headwind leave the equity-units mechanism unresolved.
DUK observed price path
DUK directional trendlines and relative performance versus sector
Snapshot at
$120.98 -0.75% Today -1.48% base
CATCHUpdated atSession 15Catch
Initial thesisThe comparison found strong individual moves, but no candidate combined a verified mechanism, current participation and durable structure without a material objection.
Published at 💬
Candidates reviewed: HAE · BDX · FSK · NREF · TToday’s public contextFSK led on relative response and participation; BDX offered the clearest issuer-linked breakout. FSK still lacked a settled source-to-price mechanism, while BDX was extended near its 52-week high. Oil prices steady as investors cautious over Iran-Oman talks Dow Futures Rise, Nasdaq Falls as Flight From Tech Gathers Pace Amid AI Fears Gold holds near seven-week peak as Hormuz hopes offset Fed tightening concerns
BEI.DEBeiersdorf AktiengesellschaftUpdated atSession 15Base: $82.20Early Try
Initial thesisBEI.DE is the committee's Early Try after a 5.12% move on 1.8x volume and 5.41% excess performance versus its index. The thesis remains conditional on sustained participation and structural follow-through; the conflicting information context is an explicit warning, not an established catalyst.
Published at 💬
Broader Market Context Record highs and Middle East relief supported the Dow and S&P, while the Nasdaq absorbed pressure from SpaceX and AMD and investors rotated across sectors. The market was broadening, but technology was no longer carrying every argument.
Latest updateBEI.DE held its tracked result at -2.31% while the latest capture fell 1.21% and finished 0.37% below VWAP near the bottom of the range. Participation improved to 0.45 times average, but Consumer Defensive weakness and the unverified event context leave the earlier repair unbuilt; the thesis still needs a supported reclaim.
BEI.DE observed price path
BEI.DE directional trendlines and relative performance versus sector
Snapshot at
$80.70 -0.25% Today -1.82% base

The coverage archive

Beyond observation

Not every published episode remains under active observation. Once an episode is closed, or belongs to the earlier legacy record, it is preserved here for reference.

This is where you can explore the coverage that came before: what was published, what changed, and how each episode eventually concluded.

View full coverage →

SHOP · Shopify Inc.

TryFinally
Initial thesis

SHOP is the Try of the Day after combining an issuer-linked information event with 18.88% excess performance, 1.81x volume and an above-VWAP upward tape. The thesis remains conditional on sustained participation and a clean hold above VWAP after a 2.81 ATR extension.

Relevant update at

SHOP's fifteen-session tracking closes at a canonical +1.88% from the $146.08 reference. The fresh final regular capture was $150.29, or +2.88% versus that reference, after a -2.33% session and -2.46% versus the prior regular close; the extended quote was $150.33 (+0.03%). Participation was 0.61x, RSI 65.80 and the EMA structure was 130.38 > 125.17 > 118.78. The original Try of the Day had an issuer-linked information event, strong relative performance and an above-average-price structure, but the path did not make continuation durable; maximum favorable excursion was +7.70% and maximum adverse excursion was -3.67%. Current 52-week position and episode-specific X evidence are unavailable. Tracking ends.

Committee read

Base $146.08 · Close $150.29

Observed return by session
S+1-0.05%S+5+1.97%S+10-0.63%S+15+1.88%
💬

XTR.L · Xtract Resources Plc

Early TryFinally
Initial thesis

XTR.L gained 8.00% with 2.54x its three-month average volume in the captured quote. Relative strength and the reviewed multi-timeframe structure were constructive, while no attributable ticker-news record was captured.

Relevant update at

XTR.L closes its fifteen-session observation at -7.41% from the 1.35 reference. The original Early Try had a strong impulse and constructive multi-timeframe structure, but the later repairs did not become durable. The fresh final market-data capture was 1.25 with 0.72x participation, RSI 66.23 and a rising EMA structure of 1.22 > 1.15 > 1.11. Episode-specific X evidence and current 52-week position data are unavailable. Tracking ends.

Committee read
Observed return by session
S+1—S+5—S+10—S+15—
💬

CATCH · Catch

Catch
Initial thesis

Broad conditions were mildly supportive: oil eased on a reported diplomatic opening and index futures edged higher, while healthcare received focus. That backdrop helped several names print gains, but the comparison split between event-driven gaps with fading intraday control and quieter charts with insufficiently specific catalysts. The result is a market with opportunity signals but no single candidate whose explanation, reaction, participation, and near-term risk line up cleanly.

Observed return by session
S+1—S+5—S+10—S+15—
💬

F · Ford Motor Company

Early TryFinally
Initial thesis

Early Try: F. F ranks first among fourteen valid prepared coiled cases for an early public review, but the thesis remains conditional on confirmation and disciplined invalidation. A United States research input is stale by one Canary day; this lowers confidence but does not veto the comparison. This is a prospective review and not an execution instruction.

Relevant update at

F's 15-session tracking closes at -1.17% from the $14.58 reference. The fresh regular capture was $14.41, up 3.00% on the session and 2.88% from the prior close on 0.69x participation; the extended quote was $14.42, up 0.07%. The original Early Try ranked F first among fourteen cases but required confirmation. The path reached +3.29% before the recovery failed. RSI 45.09 and EMA 14.34 > 14.33 > 14.12 remain available; 52-week position data and episode-specific X evidence do not. Tracking ends.

Committee read
Observed return by session
S+1—S+5—S+10—S+15—
💬

The framework behind the record

Read the method behind the conclusion.

Coverage is easier to trust when the route to the conclusion remains visible: the evidence, the panel conversation and the limits of what can be inferred.